NCT03050853
- Conditions
- Bipolar Disorder, Bipolar and Related Disorders, Chemically-Induced Disorders, +9 more
- Locations
-
- Centerstone Kentucky Louisville, Kentucky, United States
- Vinfen Corp Lawrence, Massachusetts, United States
Clinical trial condition
Schizoaffective Disorder
Explore clinical trials studying Schizoaffective Disorder. Study availability and eligibility vary by location and protocol.
450 public trials
31 recruiting studies
Schizoaffective Disorder trial results
Completed
Study Evaluating The Safety, Tolerability, And Efficacy Of Switching From Quetiapine To Ziprasidone
NCT00406315
- Conditions
- Mental Disorders, Psychotic Disorders, Schizoaffective Disorder, +2 more
- Locations
-
- Pfizer Investigational Site Phoenix, Arizona, United States
- Pfizer Investigational Site Costa Mesa, California, United States
- Pfizer Investigational Site Garden Grove, California, United States
- Pfizer Investigational Site National City, California, United States
NCT02199743
- Conditions
- Mental Disorders, Psychotic Disorders, Schizoaffective Disorder, +2 more
- Locations
-
- UT Southwestern Medical Center Dallas, Texas, United States
NCT01561859
- Conditions
- Mental Disorders, Psychotic Disorders, Schizoaffective Disorder, +2 more
- Locations
-
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- Massachusetts Institute of Technology Cambridge, Massachusetts, United States
- Massachusetts General Hospital Charlestown, Massachusetts, United States
- University of Pittsburgh Pittsburgh, Pennsylvania, United States
NCT00159770
- Conditions
- Mental Disorders, Psychotic Disorders, Schizoaffective Disorder, +2 more
- Locations
-
- Pfizer Investigational Site Aalborg, Denmark
- Pfizer Investigational Site Arhus C, Denmark
- Pfizer Investigational Site Augustenborg, Denmark
- Pfizer Investigational Site Ballerup Municipality, Denmark
NCT00650429
- Conditions
- Mental Disorders, Psychotic Disorders, Schizoaffective Disorder, +2 more
- Locations
-
- Pfizer Investigational Site Monterrey, Nuevo León, Mexico
- Pfizer Investigational Site DF, Mexico
- Pfizer Investigational Site Mexico City, Mexico
- Pfizer Investigational Site Mexico D F, Mexico
NCT00650611
- Conditions
- Bipolar Disorder, Bipolar and Related Disorders, Mental Disorders, +5 more
- Locations
-
- Pfizer Investigational Site San Diego, California, United States
- Pfizer Investigational Site Altamonte Springs, Florida, United States
- Pfizer Investigational Site Libertyville, Illinois, United States
- Pfizer Investigational Site Lexington, Kentucky, United States
NCT00649064
- Conditions
- Mental Disorders, Psychotic Disorders, Schizoaffective Disorder, +2 more
- Locations
-
- Pfizer Investigational Site Changhua, Taiwan
- Pfizer Investigational Site Tainan, Taiwan
- Pfizer Investigational Site Taipei, Taiwan
NCT00176423
- Conditions
- Cognition Disorders, Cognitive Dysfunction, Mental Disorders, +5 more
- Locations
-
- Maryland Psychiatric Research Center Baltimore, Maryland, United States
NCT02573168
- Conditions
- Mental Disorders, Psychotic Disorders, Schizoaffective Disorder, +2 more
- Locations
-
- Centre for Addiction and Mental Health Toronto, Ontario, Canada